{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:06:14Z","timestamp":1789920374246,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.sleep.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T12:34:54Z","timestamp":1428323694000},"page":"831-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial"],"prefix":"10.1016","volume":"16","author":[{"given":"Neely","family":"Ivgy-May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2015.03.005_bib0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5665\/SLEEP.1150","article-title":"Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS)","volume":"34","author":"Walsh","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biopsych.2010.10.023","volume":"69","author":"Roth","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.005_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/da.10151","article-title":"Insomnia causes, consequences, and therapeutics: an overview","volume":"18","author":"Drake","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.sleep.2015.03.005_bib0025","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.smrv.2012.01.005","article-title":"The occupational impact of sleep quality and insomnia symptoms","volume":"16","author":"Kucharczyk","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2015.03.005_bib0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.genhosppsych.2004.09.006","article-title":"Correlates and consequences of chronic insomnia","volume":"27","author":"Thase","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.005_bib0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","article-title":"Insomnia","volume":"309","author":"Buysse","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2015.03.005_bib0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/sleep\/25.6.666","article-title":"The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers","volume":"25","author":"Aslan","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-3223(00)00882-9","article-title":"Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study","volume":"48","author":"Winokur","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.005_bib0050","first-page":"A224","article-title":"A phase II. randomized, 4-way cross-over, double-blind, placebo-controlled, multicenter dose-finding trial with esmirtazapine in patients with primary insomnia","volume":"35","author":"Ruwe","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-2149-4","article-title":"Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype","volume":"215","author":"Ramaekers","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.sleep.2015.03.005_bib0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004850-200015030-00003","article-title":"Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group","volume":"15","author":"Fry","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.sleep.2015.03.005_bib0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/sleep\/30.8.959","article-title":"Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0070","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","article-title":"Insomnia pharmacotherapy","volume":"9","author":"Roehrs","year":"2012","journal-title":"Neurother"},{"key":"10.1016\/j.sleep.2015.03.005_bib0075","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6\u2009mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2011.09.006","article-title":"Efficacy and safety of doxepin 6\u2009mg in a four-week outpatient trial of elderly adults with chronic primary insomnia","volume":"13","author":"Lankford","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.005_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1715163514543856","article-title":"Use of ultra-low-dose (<\/=6\u2009mg) doxepin for treatment of insomnia in older people","volume":"147","author":"Rojas-Fernandez","year":"2014","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.sleep.2015.03.005_bib0090","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1\u2009mg, 3\u2009mg, and 6\u2009mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.005_bib0095","first-page":"23","article-title":"Suvorexant: a novel therapy for the treatment of insomnia","volume":"52","author":"Howland","year":"2014","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.sleep.2015.03.005_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/10401230209147454","article-title":"Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine","volume":"14","author":"Masand","year":"2002","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.sleep.2015.03.005_bib0105","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sleep.2015.03.005_bib0110","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1176\/appi.neuropsych.23.1.E7","article-title":"Rapid weight gain during mirtazapine treatment","volume":"23","author":"Chiu","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2015.03.005_bib0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J Affect Disord"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T13:41:21Z","timestamp":1668778881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945715006905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1389945715006905"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2015.03.005","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}